Fr170 BUDESONIDE ORODISPERSIBLE TABLETS IMPROVE THE ESOPHAGEAL DISTENSIBILITY AFTER 6-WEEK TREATMENT IN ACTIVE EOSINOPHILIC ESOPHAGITIS: RESULTS FROM A SUBSET ANALYSIS OF THE RANDOMIZED, DOUBLE-BLIND, MULTICENTER, PLACEBO-CONTROLLED EOS-1 TRIAL | Publicación